论文部分内容阅读
支气管哮喘(bronchial asthma,简称哮喘)是由多种炎症细胞,如肥大细胞、中性粒细胞、嗜酸性粒细胞、T淋巴细胞等参与的慢性炎症性气道疾病导致气道高反应性,临床表现为患者出现广泛支气管痉挛、气流受限、喘息、胸闷等哮喘发作症状及体征[1]。大多数哮喘患者可自行缓解或经治疗缓解。重度哮喘临床上少见,如果治疗不恰当,病死率极高。2012年1月至2012年12月我科采用血浆置换(placma exchange,PE)联合救治急性重度哮喘患者,取得了显著的临床疗效,现报告如下。
Bronchial asthma (asthma) is a chronic inflammatory airway disease involving a variety of inflammatory cells such as mast cells, neutrophils, eosinophils, T lymphocytes and the like, which leads to airway hyperresponsiveness. Clinical The performance of patients with extensive bronchospasm, limited airflow, wheezing, chest tightness and other symptoms and signs of asthma attacks [1]. Most asthma patients can relieve themselves or after treatment. Severe asthma clinically rare, if the treatment is not appropriate, high mortality. January 2012 to December 2012 our department using plasma exchange (placma exchange, PE) combined treatment of acute severe asthma patients, and achieved significant clinical efficacy, are as follows.